Retour
Également cotée sous
RHHBY
OTC
Fourchette du Jour
378,00 €
397,80 €
Fourchette 52 Semaines
288,90 €
514,08 €
Volume
3
Moyenne 50J / 200J
450,02 €
/
384,75 €
Clôture Précédente
375,75 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 24,6 | 0,4 |
| P/B | 9,4 | 2,9 |
| ROE % | 39,3 | 3,7 |
| Net Margin % | 20,9 | 3,8 |
| Rev Growth 5Y % | -0,5 | 10,0 |
| D/E | 1,0 | 0,2 |
Points Clés
Revenue declined -0,50% annually over 5 years
Earnings grew 55,69% over the past year
ROE of 39,30% indicates high profitability
Net margin of 20,94% shows strong profitability
Generating 14,09B in free cash flow
PEG of 0,39 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
-0,50%
Revenue (1Y)-1,36%
Earnings (1Y)55,69%
FCF Growth (3Y)10,95%
Qualité
Return on Equity
39,30%
ROIC17,98%
Net Margin20,94%
Op. Margin26,59%
Sécurité
Debt / Equity
1,02
Current Ratio1,38
Interest Coverage12,13
Valorisation
P/E Ratio
24,57
P/B Ratio9,36
EV/EBITDA21,11
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,36% | Revenue Growth (3Y) | 0,91% |
| Earnings Growth (1Y) | 55,69% | Earnings Growth (3Y) | 5,86% |
| Revenue Growth (5Y) | -0,50% | Earnings Growth (5Y) | -1,93% |
| Profitability | |||
| Revenue (TTM) | 61,55B | Net Income (TTM) | 12,89B |
| ROE | 39,30% | ROA | 12,79% |
| Gross Margin | 72,94% | Operating Margin | 26,59% |
| Net Margin | 20,94% | Free Cash Flow (TTM) | 14,09B |
| ROIC | 17,98% | FCF Growth (3Y) | 10,95% |
| Safety | |||
| Debt / Equity | 1,02 | Current Ratio | 1,38 |
| Interest Coverage | 12,13 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 24,57 | P/B Ratio | 9,36 |
| P/S Ratio | 5,14 | PEG Ratio | 0,39 |
| EV/EBITDA | 21,11 | Dividend Yield | 0,03% |
| Market Cap | 316,65B | Enterprise Value | 345,52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 61,55B | 62,40B | 60,44B | 63,28B | 62,80B |
| Net Income | 12,89B | 8,28B | 11,50B | 12,42B | 13,93B |
| EPS (Diluted) | 16,05 | 10,32 | 14,30 | 15,37 | 16,20 |
| Gross Profit | 44,89B | 46,11B | 44,08B | 42,88B | 43,15B |
| Operating Income | 16,37B | 13,42B | 15,40B | 17,48B | 18,16B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 100,75B | 101,80B | 90,47B | 88,15B | 92,32B |
| Total Liabilities | 62,85B | 65,64B | 57,21B | 56,14B | 63,97B |
| Shareholders' Equity | 33,82B | 31,77B | 29,32B | 27,99B | 24,49B |
| Total Debt | 34,45B | 36,35B | 30,78B | 26,54B | 32,55B |
| Cash & Equivalents | 5,58B | 6,98B | 5,38B | 4,99B | 6,85B |
| Current Assets | 38,75B | 40,04B | 33,45B | 33,82B | 35,63B |
| Current Liabilities | 28,01B | 27,02B | 24,82B | 27,24B | 38,42B |